Form 8-K - Current report:
SEC Accession No. 0001641172-25-014075
Filing Date
2025-06-06
Accepted
2025-06-06 16:30:16
Documents
12
Period of Report
2025-06-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37776
  Complete submission text file 0001641172-25-014075.txt   201084

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE orgs-20250606.xsd EX-101.SCH 3017
3 XBRL LABEL FILE orgs-20250606_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE orgs-20250606_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3535
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 251031153
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)